AIM
AGN

Alhambra Investment Management’s Allergan plc AGN Stock Holding History

Alhambra Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,114
Closed -$213K – 121
2019
Q4 		$213K Buy
+1,114
New +$201K 0.25% 113

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alhambra Investment Management's AGN Position: Q1 2020 in Review

Alhambra Investment Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,114 shares — an estimated $213K sold.

Alhambra Investment Management first reported a position in AGN in Q4 2019 and held it in 1 quarter. The position peaked at $213K in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Alhambra Investment Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Alhambra Investment Management sold 1,114 Allergan plc shares in Q1 2020, an estimated $213K.
  • Alhambra Investment Management first reported a position in Allergan plc in Q4 2019 and held it in 1 quarter.
  • Alhambra Investment Management's Allergan plc position peaked at $213K in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Alhambra Investment Management's 13F filing for Q1 2020, filed 30 Apr 2020.